Acne Academy - Professional Pages

Who are we?

The Acne Academy has been developed by a team of leading UK medical professionals – including dermatologists, a GP with a special interest in dermatology, dermatology specialist nurse and a pharmacist. Acne Academy has been written by this team of UK healthcare professionals who have all volunteered their time to produce this resource.
 

Development of the website has been funded by an unrestricted educational grant from Astellas, Clinique, Dermal Laboratories Ltd, Galderma, Stiefel, Ying Yang and P&G Beauty and Grooming.  These companies have had no influence on the content of this website resource except for providing a review for medical accuracy and overall compliance with the requirements of the ABPI Code of Practise.

Safe, effective treatments are out there, but sometimes it can be a difficult to work out what's going to work for your patient. So why not get the real experts to help?

All About Acne is a medical information resource only. We do not see patients and cannot provide a referral or recommendation for any medical professional. 

Why use this website?

Acne is very common – affecting 80% of people at some point in their lives – most often (but not always) during the teenage years. Other age groups can also be affected. Acne is a relatively common cause for consultations with health professionals.

This section of the website aims to give healthcare professionals accurate, balanced and practical information about acne, including how to diagnose acne, what treatments to use and when to refer. It also provides links to other websites and guidelines that we consider will be useful.

Dr Alison Layton comments . . . . .

'Acne is the commonest inflammatory dermatoses seen in Dermatology Clinics.  It causes significant psychological and social disability and may lead to clinically relevant scarring.  The need to optimise the treatment of acne is therefore paramount.  Treatments have historically depended on the use of long term anti-biotics but there is now significant concern relating to the emergence of anti-biotic resistant acne bacteria.  Patients harbouring these resistant organisms will respond less well to therapy and minimising the development of bacterial resistance in the wider community is clearly of great importance. 

Clinicians need to consider the use of targeted therapeutic regimes currently available, aimed at avoiding bacterial resistance, achieving maximum and rapid efficacy and avoiding potential adverse effects.'